Korsana Biosciences, Inc. (KRSA) vs Nyxoah S.A. (NYXH)
A side-by-side comparison of Korsana Biosciences, Inc. and Nyxoah S.A. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KRSA
Korsana Biosciences, Inc.
$31.51HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
NYXH
Nyxoah S.A.
$1.43HealthcareDelayed quote: Oct 6, 2026, 11:24 AM EDT
Total return — KRSA vs NYXH
growth of $100 · dividends reinvested · last 5yKRSA -91.4% (-38.8%/yr)NYXH -94.1% (-43.3%/yr)KRSA compounded faster over this window
KRSA NYXH
KRSA vs NYXH: by the numbers
- •KRSA is the larger company ($147M vs $143M market cap).
- •Both run net losses; KRSA's is the smaller (-353.00% vs -435.70% net margin).
- •NYXH grew revenue faster over the past five years (120.68% vs -11.98% CAGR).
Metrics side by side
Valuation
| Metric | KRSA | NYXH |
|---|---|---|
| P/S ratio | 77.62 | 5.46 |
| P/B ratio | 28.99 | 1.51 |
Profitability
| Metric | KRSA | NYXH |
|---|---|---|
| Gross margin | 100.00% | 63.13% |
| Operating margin | -239.78% | -827.76% |
| Net margin | -353.00% | -435.70% |
| ROE | -131.85% | -120.33% |
| ROIC | -134.15% | -61.13% |
Growth (annualized)
| Metric | KRSA | NYXH |
|---|---|---|
| Revenue CAGR (5Y) | -11.98% | 120.68% |
| Total return CAGR (5Y) | -40.41% | -45.84% |
Frequently asked
- Which has grown faster, KRSA or NYXH?
- Over the past five years, NYXH grew revenue faster — KRSA at a -11.98% CAGR versus NYXH at 120.68%.
- How have KRSA and NYXH total returns compared?
- Over the past 5 years, KRSA delivered -40.41% and NYXH delivered -45.84% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Korsana Biosciences ROENyxoah ROEKorsana Biosciences operating marginNyxoah operating marginKorsana Biosciences revenue growthNyxoah revenue growthKorsana Biosciences free cash flowNyxoah free cash flow
Korsana Biosciences & Nyxoah appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.